US equities
|
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
ANT
$97.17
▲+17.07%
NVDA
$145.98
▼-3.30%
AMD
$489.19
▼-7.72%
MU
$690.44
▼-2.10%
SPCX
$138.43
▼-3.53%
MSFT
$498.30
▼-1.97%
AAPL
$349.21
▼-0.92%
AMZN
$257.37
▼-3.87%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about MedPharm
Recent news which mentions MedPharm
DEA's Cannabis Rescheduling Hearing Set To Begin In January 2025 As Controversy Mounts
December 06, 2024
Tickers
DEA
NEWS
Tags
Doctors for Drug Policy Reform
MedPharm
cannabis rescheduling
From
Benzinga
DEA Judge Blocks Researcher's Motion In Cannabis Rescheduling Case,
November 25, 2024
Tickers
DEA
NEWS
Tags
Benzinga
Market News
Cannabis Lawsuit
From
Benzinga
MedPharm Cannabis Research In Alzheimer's Disease Gets Funding
July 21, 2022
Tags
Colorado State University Institute of Cannabis Research
MedPharm Research
News
From
Benzinga